- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 243/38 - Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to carbon atoms of six-membered aromatic rings
Patent holdings for IPC class C07C 243/38
Total number of patents in this class: 119
10-year publication summary
10
|
17
|
9
|
7
|
9
|
12
|
5
|
6
|
7
|
2
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Intrexon Corporation | 110 |
9 |
HMI Medical Innovations, LLC | 16 |
8 |
Otsuka Chemical Co., Ltd. | 290 |
8 |
Corteva Agriscience LLC | 2662 |
6 |
Bridgestone Corporation | 7243 |
4 |
Dana-Farber Cancer Institute, Inc. | 2558 |
4 |
Theravance Biopharma R&D IP, LLC | 460 |
4 |
Merck Patent GmbH | 5861 |
3 |
President and Fellows of Harvard College | 5957 |
3 |
Eurofarma Laboratorios S.A. | 34 |
3 |
RF Therapeutics Inc. | 4 |
3 |
Universidade Federal do Rio de Janeiro-ufrj | 87 |
3 |
University of Florida Research Foundation, Inc. | 4000 |
2 |
Ludwig-Maximilians-Universitat Munchen | 345 |
2 |
NDSU Research Foundation | 245 |
2 |
Ottawa Hospital Research Institute | 108 |
2 |
Yale University | 2368 |
2 |
E. I. du Pont de Nemours and Company | 4107 |
1 |
Allergan, Inc. | 2361 |
1 |
Bayer Cropscience AG | 2055 |
1 |
Other owners | 48 |